Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen Capsules for COVID-19 pneumonia
ChiCTR2000029434Phase 4Completed
- Sponsor
- Hebei Yiling Hospital
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Lianhua Qingwen in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by Hebei Yiling Hospital. Primary endpoint: Clinical symptom recovery rate and recovery time. Started Feb 2020; status: completed.
02
Drugs
Lianhua Qingwen
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on ChiCTR2000029434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029434.